FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use
Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:LMNA-NTRK1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: LMNA-NTRK1
FusionPDB ID: 45793
FusionGDB2.0 ID: 45793
HgeneTgene
Gene symbol

LMNA

NTRK1

Gene ID

4000

4914

Gene namelamin A/Cneurotrophic receptor tyrosine kinase 1
SynonymsCDCD1|CDDC|CMD1A|CMT2B1|EMD2|FPL|FPLD|FPLD2|HGPS|IDC|LDP1|LFP|LGMD1B|LMN1|LMNC|LMNL1|MADA|PRO1MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA
Cytomap

1q22

1q23.1

Type of geneprotein-codingprotein-coding
Descriptionlamin70 kDa laminepididymis secretory sperm binding proteinlamin A/C-like 1mandibuloacral dysplasia type Aprelamin-A/Crenal carcinoma antigen NY-REN-32high affinity nerve growth factor receptorOncogene TRKTRK1-transforming tyrosine kinase proteingp140trkneurotrophic tyrosine kinase, receptor, type 1tropomyosin-related kinase Atyrosine kinase receptor A
Modification date2020032920200313
UniProtAcc

P02545

Main function of 5'-partner protein: FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Recruited by DNA repair proteins XRCC4 and IFFO1 to the DNA double-strand breaks (DSBs) to prevent chromosome translocation by immobilizing broken DNA ends (PubMed:31548606). Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:22431096, PubMed:10814726, PubMed:11799477, PubMed:18551513). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477, ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:23666920, ECO:0000269|PubMed:31548606}.; FUNCTION: Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence.

P04629

Main function of 5'-partner protein: FUNCTION: Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand (PubMed:1850821, PubMed:1849459, PubMed:1281417, PubMed:8325889, PubMed:15488758, PubMed:22649032, PubMed:17196528, PubMed:27445338). Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival (By similarity). Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation (PubMed:1281417). Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors. {ECO:0000250|UniProtKB:P35739, ECO:0000250|UniProtKB:Q3UFB7, ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528, ECO:0000269|PubMed:1849459, ECO:0000269|PubMed:1850821, ECO:0000269|PubMed:22649032, ECO:0000269|PubMed:27445338, ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:8155326, ECO:0000269|PubMed:8325889}.; FUNCTION: [Isoform TrkA-III]: Resistant to NGF, it constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed. {ECO:0000269|PubMed:15488758}.
Ensembl transtripts involved in fusion geneENST idsENST00000347559, ENST00000361308, 
ENST00000368297, ENST00000368299, 
ENST00000368300, ENST00000368301, 
ENST00000392353, ENST00000448611, 
ENST00000473598, ENST00000496738, 
ENST00000531606, ENST00000358660, 
ENST00000368196, ENST00000392302, 
ENST00000524377, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score16 X 16 X 9=230425 X 24 X 13=7800
# samples 2133
** MAII scorelog2(21/2304*10)=-3.45567948377619
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(33/7800*10)=-4.56293619439116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: LMNA [Title/Abstract] AND NTRK1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: LMNA [Title/Abstract] AND NTRK1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)LMNA(156100564)-NTRK1(156844698), # samples:2
Anticipated loss of major functional domain due to fusion event.LMNA-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LMNA-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LMNA-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
LMNA-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
LMNA-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
LMNA-NTRK1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
LMNA-NTRK1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
LMNA-NTRK1 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneLMNA

GO:0090343

positive regulation of cell aging

20458013

TgeneNTRK1

GO:0006468

protein phosphorylation

15488758

TgeneNTRK1

GO:0008285

negative regulation of cell proliferation

15488758

TgeneNTRK1

GO:0010976

positive regulation of neuron projection development

15488758

TgeneNTRK1

GO:0018108

peptidyl-tyrosine phosphorylation

2927393

TgeneNTRK1

GO:0043547

positive regulation of GTPase activity

15488758

TgeneNTRK1

GO:0046579

positive regulation of Ras protein signal transduction

15488758

TgeneNTRK1

GO:0046777

protein autophosphorylation

15488758

TgeneNTRK1

GO:0048011

neurotrophin TRK receptor signaling pathway

15488758

TgeneNTRK1

GO:0051092

positive regulation of NF-kappaB transcription factor activity

15488758

TgeneNTRK1

GO:0070374

positive regulation of ERK1 and ERK2 cascade

15488758

TgeneNTRK1

GO:1904646

cellular response to amyloid-beta

11927634



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:156100564/chr1:156844698)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across LMNA (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across NTRK1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)
ENST00000368301LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+244611545122293593
ENST00000368301LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+250211545122293593
ENST00000368301LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+229411545122293594
ENST00000368301LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+237211545122302596
ENST00000361308LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+20547621201901593
ENST00000361308LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+21107621201901593
ENST00000361308LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+19027621201901593
ENST00000361308LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+19807621201910596
ENST00000347559LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+20547621201901593
ENST00000347559LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+21107621201901593
ENST00000347559LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+19027621201901593
ENST00000347559LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+19807621201910596
ENST00000368300LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+2017725831864593
ENST00000368300LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+2073725831864593
ENST00000368300LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+1865725831864594
ENST00000368300LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+1943725831873596
ENST00000368299LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+2002710681849593
ENST00000368299LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+2058710681849593
ENST00000368299LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+1850710681849594
ENST00000368299LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+1928710681858596
ENST00000448611LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+151322181360450
ENST00000448611LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+156922181360450
ENST00000448611LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+136122181360451
ENST00000448611LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+143922181369453
ENST00000368297LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+16643721021511469
ENST00000368297LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+17203721021511469
ENST00000368297LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+15123721021511469
ENST00000368297LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+15903721021520472
ENST00000473598LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+1628336841475463
ENST00000473598LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+1684336841475463
ENST00000473598LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+1476336841475463
ENST00000473598LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+1554336841484466
ENST00000392353LMNAchr1156100564+ENST00000392302NTRK1chr1156844698+156227001409469
ENST00000392353LMNAchr1156100564+ENST00000368196NTRK1chr1156844698+161827001409469
ENST00000392353LMNAchr1156100564+ENST00000524377NTRK1chr1156844698+141027001409469
ENST00000392353LMNAchr1156100564+ENST00000358660NTRK1chr1156844698+148827001418472

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000368301ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.0165905860.9834094
ENST00000368301ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.0156549590.984345
ENST00000368301ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.0190526770.9809473
ENST00000368301ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.017978210.9820218
ENST00000361308ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.0201337910.9798662
ENST00000361308ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.018860120.9811399
ENST00000361308ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.0235555940.9764445
ENST00000361308ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.021789260.97821075
ENST00000347559ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.0201337910.9798662
ENST00000347559ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.018860120.9811399
ENST00000347559ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.0235555940.9764445
ENST00000347559ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.021789260.97821075
ENST00000368300ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.0206782520.9793218
ENST00000368300ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.0192861840.9807138
ENST00000368300ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.0242015760.97579837
ENST00000368300ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.0224349240.97756505
ENST00000368299ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.0212062080.97879374
ENST00000368299ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.0197022690.98029774
ENST00000368299ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.024870310.9751297
ENST00000368299ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.0229606130.9770394
ENST00000448611ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.043352880.9566471
ENST00000448611ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.0424679260.95753205
ENST00000448611ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.043836510.9561635
ENST00000448611ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.0339012260.96609885
ENST00000368297ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.031967830.9680322
ENST00000368297ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.0316037760.9683962
ENST00000368297ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.0313878360.9686122
ENST00000368297ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.0338585530.9661414
ENST00000473598ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.020196240.9798038
ENST00000473598ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.020035230.97996473
ENST00000473598ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.0204824750.9795176
ENST00000473598ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.0162346140.9837654
ENST00000392353ENST00000392302LMNAchr1156100564+NTRK1chr1156844698+0.0319960680.9680039
ENST00000392353ENST00000368196LMNAchr1156100564+NTRK1chr1156844698+0.032166070.967834
ENST00000392353ENST00000524377LMNAchr1156100564+NTRK1chr1156844698+0.031511120.9684889
ENST00000392353ENST00000358660LMNAchr1156100564+NTRK1chr1156844698+0.0339577940.96604216

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for LMNA-NTRK1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide

Top

Potential FusionNeoAntigen Information of LMNA-NTRK1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Potential FusionNeoAntigen Information of LMNA-NTRK1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of LMNA-NTRK1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of LMNA-NTRK1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score

Top

Vaccine Design for the FusionNeoAntigens of LMNA-NTRK1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of LMNA-NTRK1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample

Top

Potential target of CAR-T therapy development for LMNA-NTRK1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneNTRK1chr1:156100564chr1:156844698ENST00000368196816424_4390791.0TransmembraneHelical
TgeneNTRK1chr1:156100564chr1:156844698ENST00000392302917424_4390761.0TransmembraneHelical
TgeneNTRK1chr1:156100564chr1:156844698ENST00000524377917424_4390797.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to LMNA-NTRK1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to LMNA-NTRK1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneNTRK1C0020074HSAN Type IV17CTD_human;GENOMICS_ENGLAND;UNIPROT
TgeneNTRK1C0238463Papillary thyroid carcinoma3ORPHANET
TgeneNTRK1C0002768Congenital Pain Insensitivity1ORPHANET
TgeneNTRK1C0005586Bipolar Disorder1CTD_human
TgeneNTRK1C0005587Depression, Bipolar1CTD_human
TgeneNTRK1C0017638Glioma1CTD_human
TgeneNTRK1C0020075Hereditary Sensory Autonomic Neuropathy, Type 51CTD_human;ORPHANET
TgeneNTRK1C0024713Manic Disorder1CTD_human
TgeneNTRK1C0027796Neuralgia1CTD_human
TgeneNTRK1C0027819Neuroblastoma1CTD_human
TgeneNTRK1C0033958Psychosis, Brief Reactive1CTD_human
TgeneNTRK1C0033975Psychotic Disorders1CTD_human
TgeneNTRK1C0036337Schizoaffective Disorder1CTD_human
TgeneNTRK1C0036341Schizophrenia1CTD_human
TgeneNTRK1C0036358Schizophreniform Disorders1CTD_human
TgeneNTRK1C0038870Neuralgia, Supraorbital1CTD_human
TgeneNTRK1C0042656Neuralgia, Vidian1CTD_human
TgeneNTRK1C0234247Neuralgia, Atypical1CTD_human
TgeneNTRK1C0234249Neuralgia, Stump1CTD_human
TgeneNTRK1C0259783mixed gliomas1CTD_human
TgeneNTRK1C0273115Lung Injury1CTD_human
TgeneNTRK1C0338831Manic1CTD_human
TgeneNTRK1C0423711Neuralgia, Perineal1CTD_human
TgeneNTRK1C0423712Neuralgia, Iliohypogastric Nerve1CTD_human
TgeneNTRK1C0555198Malignant Glioma1CTD_human
TgeneNTRK1C0598589Inherited neuropathies1GENOMICS_ENGLAND
TgeneNTRK1C0751371Neuralgia, Ilioinguinal1CTD_human
TgeneNTRK1C0751372Nerve Pain1CTD_human
TgeneNTRK1C0751373Paroxysmal Nerve Pain1CTD_human
TgeneNTRK1C0752347Lewy Body Disease1CTD_human
TgeneNTRK1C1833921Familial medullary thyroid carcinoma1CTD_human;GENOMICS_ENGLAND;ORPHANET
TgeneNTRK1C2350344Chronic Lung Injury1CTD_human